Eli Lilly and Company (FRA:LLY)
660.20
+7.20 (1.10%)
At close: Jul 22, 2025, 10:00 PM CET
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $12.73B USD in the quarter ending March 31, 2025, with 45.17% growth. This brings the company's revenue in the last twelve months to $49.00B, up 36.38% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$49.00B
Revenue Growth
+36.38%
P/S Ratio
13.10
Revenue / Employee
$1.04M
Employees
47,000
Market Cap
593.88B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 109.03B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Siemens Healthineers AG | 23.14B |
Eli Lilly and Company News
- 2 days ago - 15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them - Market Watch
- 2 days ago - Eli Lilly: Competition Melts Away - Seeking Alpha
- 3 days ago - Weight loss drugs could be a gamechanger for women with a common hormonal disorder - CNBC
- 4 days ago - Calls of the Day: Eli Lilly and Materion - CNBC
- 4 days ago - tech giants stumble as Tesla accelerates: Unpacking today's mixed market signals - Forexlive
- 5 days ago - Can Eli Lilly Stock Withstand the Threat of President Trump's New Sweeping Tariffs? - The Motley Fool
- 6 days ago - Ozempic, Mounjaro Users Cut $6.5 Billion From Grocery Bills: GLP-1 Boom Triggers Panic In Packaged Food Aisles - Benzinga
- 7 days ago - Eli Lilly (LLY) Gains Canadian Approval for Crohn's Disease Drug Omvoh - GuruFocus